Hrt Financial LP Biond Vax Pharmaceuticals Ltd. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.48 - $2.92 $52,736 - $104,048	-35,633 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.44 $7,099 - $11,358	3,302 Added 10.21%	35,633 $78,000
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.91 $962 - $1,446	370 Added 1.16%	32,331 $92,000
Q1 2021 May 17, 2021	BUY	$3.1 - $5.95 $99,079 - $190,167	31,961 New	31,961 $121,000

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.